+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Vaccine Manufacturing"

South America Vaccines Market Outlook, 2028 - Product Thumbnail Image

South America Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 89 Pages
From
North America Vaccines Market Outlook, 2028 - Product Thumbnail Image

North America Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 101 Pages
  • North America
From
Asia-Pacific Vaccines Market Outlook, 2028 - Product Thumbnail Image

Asia-Pacific Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 107 Pages
  • Asia Pacific
From
Europe Vaccines Market Outlook, 2028 - Product Thumbnail Image

Europe Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 112 Pages
  • Europe
From
From
Drug Overview: TetraVax-DV - Product Thumbnail Image

Drug Overview: TetraVax-DV

  • Drug Pipelines
  • January 2018
  • 16 Pages
  • Global
From
Loading Indicator

The Vaccine Manufacturing market is a subset of the biopharmaceutical industry, which focuses on the development and production of vaccines. Vaccines are biological products that are used to prevent and treat infectious diseases. Vaccine manufacturing involves the production of active ingredients, such as antigens, as well as the formulation and packaging of the final product. Vaccine manufacturers must adhere to strict regulatory standards to ensure the safety and efficacy of their products. The Vaccine Manufacturing market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more